Description
Prescription Required:Medicyte Pharmaceuticals Pvt Ltd:<medicine_type>:
Vildagliptin (50mg):<packagingdetail>:Strip:
10:<productform>::Store below 30°C:
:CONSULT YOUR DOCTOR:CONSULT YOUR DOCTOR:
UNSAFE::UNSAFE
Medicyte Pharmaceuticals Pvt Ltd | SHOP NO.3, ABHIYANTA CHS LTD., PLOT NO.64A SECTOR-21, KHARGHAR NAVI MUMBAI Raigarh MH 410210 IN , – , .::Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
:<country_of_origin>
When should I take Adglip 50mg Tablet?::: You can take Adglip 50mg Tablet tablets before, with or after meals. If you have been prescribed to take this medicine once daily, then take it in the morning. In case you have to take it twice daily, then you should prefer taking the first dose in the morning and the second dose in the evening.| Does Adglip 50mg Tablet cause hypoglycemia?::: Yes, Adglip 50mg Tablet may cause hypoglycemia (low blood sugar), but the chances are lesser as compared to other antidiabetic drugs. Evidence suggests that treatment with Adglip 50mg Tablet has been shown to cause hypoglycemia in very rare cases. The risk is low even in those who are prone to hypoglycemia like elderly people or people being treated with insulin. However, the chance of hypoglycemia increases if Adglip 50mg Tablet is taken along with other antidiabetic drugs.| Does Adglip 50mg Tablet cause weight gain?::: No, Adglip 50mg Tablet does not cause weight gain. Moreover, medicines, such as Adglip 50mg Tablet, are generally supposed to decrease weight since they act by increasing satiety (feeling of fullness) and delaying emptying of the stomach. This further decreases hunger, restricting the patient from eating more than required.| Is Adglip 50mg Tablet the same as sitagliptin?::: No, Adglip 50mg Tablet is not the same as Sitagliptin, but both drugs belong to the same class. Additionally, these two drugs have a similar mechanism of decreasing blood glucose levels.:
Chemical Class :: Pyrrolidine-carbonitrile derivative|Habit Forming :: No|Therapeutic Class :: ANTI DIABETIC|Action Class :: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
